Skip to main content
PLOS One logoLink to PLOS One
. 2022 Jun 22;17(6):e0270102. doi: 10.1371/journal.pone.0270102

Prevalence and associated risk factors for mental health problems among patients with polycystic ovary syndrome in Bangladesh: A nationwide cross—Sectional study

Moynul Hasan 1, Sumaya Sultana 1, Md Sohan 2, Shahnaj Parvin 1, Md Ashrafur Rahman 3, Md Jamal Hossain 4, Mohammad Saydur Rahman 1, Md Rabiul Islam 2,*
Editor: Kenji Hashimoto5
PMCID: PMC9216580  PMID: 35731829

Abstract

Background

Polycystic ovary syndrome (PCOS) is a common female reproductive endocrine problem worldwide. The prevalence of mental disorder is increasing among PCOS patients due to various physical, psychological, and social issues. Here we aimed to evaluate the mental health and associated factors among women suffering from PCOS in Bangladesh.

Methods

We performed an online cross-sectional survey among 409 participants with PCOS using Google Forms. We used structured questionnaires to collect socio-demographic information and lifestyle-related factors. Also, we applied patient health questionnaire (PHQ-9), generalized anxiety disorder (GAD-7) scale, and UCLA loneliness (UCLA-3) scale for psychometric assessment of the participants. Finally, we applied several statistical tools and performed data interpretations to evaluate the prevalence of mental health disorders and associated factors among patients with PCOS in Bangladesh.

Results

Prevalence of loneliness, generalized anxiety disorder and depressive illness among the women with PCOS were 71%, 88%, and 60%, respectively. Among the mental illness, mild, moderate, and severe cases were 39%, 18%, and 14% for loneliness; 39%, 23% and 26% for generalized anxiety disorder; and 35%, 18%, and 7% for depressive disorder. According to the present findings, obesity, financial condition, physical exercise, mealtime, food habit, daily water consumption, birth control method, and long-term oral contraceptive pills contribute to developing mental health disorders among females with PCOS in Bangladesh.

Conclusion

According to present study results, high proportion of women suffering from PCOS experience several mental disorders in Bangladesh. Although several socio-demographic and lifestyle-related factors were found to be associated with the poor mental health of women with PCOS; however, PCOS itself is a condition that favors poor physical and psychological health. Therefore, we recommend proper treatment, public awareness, and a healthy lifestyle to promote the good mental health of women suffering from PCOS.

Introduction

Polycystic ovary syndrome (PCOS) is a complex heterogeneous endocrine disorder related to the reproductive disease of females. In the female ovarian antral follicles, many cysts are seen to develop due to the improper balance of female sex hormones [14]. The prognosis of PCOS can be determined by examining three interconnected symptoms such as hyperandrogenism, ovulation disorders, or PCOM (polycystic ovary morphology) [5]. Hyperandrogenism can be identified by some visible signs including growing fatter, abdominal and subcutaneous fat, facial and body hair, hair loss, enlargement of the clitoris, deep voice, oily skin, acne, etc. [6]. One of the significant symptoms of PCOS is insulin resistance (IR). It is responsible for hyperinsulinemia leading to type II diabetes mellitus [7]. Another significant symptom of PCOS is sleep apnea, which occurs due to an imbalance in the sex steroid levels [8]. The etiology or genesis of this disease has not been fully known. There has been significant discussion concerning the genesis and pathological relationship of PCOS [9]. PCOS can be caused by a variety of reasons. PCOS can be caused by either genetics or a poor lifestyle, or a combination of both [1, 2]. According to several studies, a deficiency in insulin function may be the root cause of PCOS [1012]. A dysfunction in the thyroid gland, CAH (congenital adrenal hyperplasia), elevated serum prolactin hormone, androgen-secreting tumors, and Cushing’s syndrome are among the factors that might contribute to PCOS pathogenesis [2]. Depending on diagnostic criteria, it is found that PCOS is common among 21.27% of women [13]. In developed countries, the prevalence of PCOS is about 6–10% [14]. In Bangladesh, a significant percentage of women have been suffering from PCOS [15].

Women with PCOS have experienced adverse social, physical, emotional, and psychological consequences that negatively impacted their health-related quality of life [16]. As a result, their social and interpersonal relationships are hampered [17]. They experienced pessimistic, mocking behavior during treatment, which made them stressed and more discouraged. Even if they did not get enough support from their family members and they might be isolated from their families [18]. Therefore, they experience humiliation from society. Moreover, obesity, hirsutism, hair loss, menstrual abnormalities, and facial acne harmed their physical health. Furthermore, impaired infertility makes them humiliated and lowers their self-confidence [17]. Women with PCOS frequently report that they feel less attraction to their sexual life [19]. These reasons may justify a high divorce rate among women with PCOS [20]. Therefore, they are more prone to have psychological issues such as anxiety, depression, sadness, and loneliness than others [21, 22].

The prevalence of depression and anxiety symptoms is high among individuals with PCOS [23]. Several studies revealed that PCOS has a detrimental impact on the mental health of patients. Another study reported that 70–74% of PCOS patients were obese which indicates a high level of dissatisfaction regarding their physical appearance [24]. A correlation has been found between physical obesity and depressive symptoms in the case of PCOS patients [2527]. Also, anxiety is the most frequent psychological condition among women with PCOS [28, 29].

Anxiety can cause social isolation, lower quality of life, and increase the chance of developing another mental illness [29]. The development of anxiety symptoms in patients with PCOS is common [26]. Anxiety intensifies parallelly with the gradual development of hyperinsulinemia as well as hyperandrogenism, which are the typical symptoms of PCOS. Such parallel relation with anxiety is also found in the case of hormonal abnormalities of individuals with PCOS. It was found that women with PCOS who had a higher level of anxiety had more severe depression, indicating a possible relationship between these psychological disorders in PCOS women [29]. Thus, solid proof of a close relation between PCOS and psychological disorders is established.

There are several sex-specific factors involved in the poor mental health of women in Bangladesh [3033]. Individuals with PCOS have to face many psycho-social problems in Bangladesh [34]. However, there are no studies in Bangladesh that adequately evaluated the mental health of women suffering from PCOS. Therefore, we aimed to assess the mental health of women suffering from PCOS in Bangladesh. Also, we tried to find the associated risk factors for the poor mental health of PCOS patients. We believe the present study findings will help to improve the quality of life of women suffering from PCOS.

Materials and methods

Study design and participants

We accomplished this cross-sectional online survey using Google Forms from June 15, 2021, to October 15, 2021. We consider the margin of error, response rate, and confidence level to be about 5%, 50%, and 95%, respectively. We required 384 responses to achieve 80% statistical power based on this distribution. Initially, we received responses from a total of 444 respondents. After sorting out all the answers, we ignored 35 respondents due to providing incomplete or partial information. After this step, we selected 409 respondents between 15 to 45 years of age. The objective of this study, eligibility requirement, and procedure of this study were known by all participants. At the initial stage of this survey, we obtained an electronic consent form from all participants. All respondents for the present study were of Bangladeshi nationality and lived in Bangladesh at the time of data collection. We included participants with a confirmed diagnosis of PCOS in this study. Participants over the age of 45 and under 18 were excluded from this study. The information was provided voluntarily by all participants.

Estimations

We gathered information to find a correlation between the recent demographic profile and lifestyle-related factors with mental health problems among patients with PCOS. Later, with the help of mental health evaluation tools, we assessed the degrees of loneliness, depression, and generalized anxiety. We used a pre-structured questionnaire set developed by researchers to obtain the required information. At first, questionnaires were prepared in English and then converted into Bangla. To translate the questions, we took help from two Bangla native speakers (a medical graduate and a nonmedical individual) who have expertise in the English language. An independent author combined the translated versions to form a single Bangla forward version, and discrepancies were resolved with the assistance of a third author. A professional translator with experience in medical translation translated this Bangla version into English. An independent researcher combined these back-translated versions to create a single English version [35]. Then, we conducted a preliminary test among the randomly selected small participants group to confirm the clarity and understanding of the questions. We excluded this pilot-testing information from the final study population data. Finally, we delivered the survey questionnaire in both Bangla and English to guarantee adequate comprehension. We collected information by sending the link to the questionnaire to participants via e-mail, Facebook, Messenger, WhatsApp as well as other social media platforms. We assisted with video conferences or phone conversations to resolve any issues or concerns regarding the questionnaire.

Socio-demographic and biophysical measures

Most relevant socio-demographic information related to our study was collected from our respondents. We collected the most relevant sociodemographic information from the respondents. Collected data were regarding age, body mass index (BMI), marital status, education, economic impression, residence area, living status (with or without family), smoking habit, and family history of PCOS.

Patient health questionnaire

The patient health questionnaire-9 (PHQ-9) is a globally recognized questionnaire having nine different questions to evaluate the depressive symptoms of respondents [36]. The total score for these self-administered questions ranges from 0 to 27 as the score allocated for each question is from 0 to 3 (0 = not at all; 1 = several days; 2 = more than a week; 3 = nearly every day). To express different levels of depression, the total score is divided into four distinct parts named as mild depression if the score is ≤9; 10–14 moderate depression if the score is 10–14; moderately severe depression if the score is 15–19 and severe depression if the score is ≥20 [3741].

Generalized anxiety disorder scale

The generalized anxiety disorder 7-item (GAD-7) scale is a valid and efficient tool for evaluating generalized anxiety symptoms. This scale has seven different questions for assessing symptoms if they persist for at least two weeks. Each question has four other scores ranging from 0 to 3 where 0 means “Not at all”, 1 means “Several days”, 2 means “more than half the days”, and 3 means “Nearly every day”. The total score for the GAD-7 ranges from 0 to 27, separated into four different segments indicating a different degree of anxiety (≤4 scores indicate no anxiety, 5–9 scores indicate mild anxiety, 10–14 scores indicate moderate anxiety and ≥15 scores indicate severe anxiety) [42].

Loneliness scale

To calculate the degree of loneliness among respondents, we used UCLA Loneliness Scale (Version 3). This scale was created to make the response format easier to understand. It contains a total of 20 questions "How often do you feel" at the beginning of each question. This version of the UCLA Loneliness Scale includes 11 negatively phrased (lonely) and 9 positively phrased (non-lonely) questions. Here, the respondents had four options to respond: ‘Never’, ‘Rarely’, ‘Sometimes’, and ‘Always’ with scores 1,2,3, and 4, respectively. The score was reversed in the case of positively stated questions (i.e., 1 = 4, 2 = 3, 3 = 2, and 4 = 1). After then, the scores for each question are summed together; higher scores indicate greater degrees of loneliness [43].

Data analysis

The data analysis was performed with the help of Microsoft Excel 2019 and Statistical Packages for Social Sciences (IBM SPSS) V.25.0. We utilized Microsoft Excel for data processing, sorting, coding, categorization, and tabulation. We next loaded the Excel file into the IBM SPSS program. Briefly, descriptive statistics were applied to analyze the characteristics of the study participants. To examine the differences between the group statistics, we performed the chi-square test. Binary logistic regression analysis was applied to find the risk ratios of having mental health problems due to socio-demographic and life-style related factors among participants. We evaluated statistically significant findings from analyses at p<0.05.

Ethics

The Research Ethics Committee of the Department of Pharmacy, Jagannath University, Dhaka, Bangladesh, reviewed and approved the study protocol (Ref: 003/2021). We conducted the present study following the principles stated in the Declaration of Helsinki. Also, we briefed the objective and purpose of this study at the beginning of the questionnaire. We obtained electronic consent from each patient before taking part in this study.

Results

Characteristics of respondents

The socio-demographic profile of the respondents was demonstrated in Table 1. Among 409 females, most of them (60.15%) were between 15–25 years of age, a significant proportion (36.67%) of them were between 26–35 years of age, and minor respondents (3.18%) were between 36–45 years of age. According to our analysis, we found that more than half (52.81%) of participants were married. Most of them were graduates (73.11%), low economic background women (60.39%), and non-smokers (95.84%). About 90.71% of women lived with their families, and around one-fifth (21.03%) of respondents were from rural areas.

Table 1. Distribution of socio-demographic variables and their association with mental health problems among the patients suffering from the polycystic ovarian syndrome.

Socio-demographic parameters Total (N = 409) Loneliness (N = 289) Generalized anxiety disorder (N = 359) Depressive disorder (N = 244)
n % n % χ2 df p- value n % χ2 df p- value n % χ2 df p- value
Age in years
    18–25 246 60.15 175 60.554 0.071 2 0.965 219 61.003 0.919 2 0.632 14
5
59.43 1.379 2 0.502
    26–35 150 36.67 105 36.332 129 35.933 93 38.11
    36–45 13 3.18 9 3.114 11 3.064 6 2.46
Marital status
    Married 216 52.81 147 50.87 1.498 1 0.221 188 52.37 0.232 1 0.630 12
4
50.82 0.963 1 0.326
    Unmarried 193 47.19 142 49.13 171 47.63 120 49.18
BMI (kg/m2)
    Below 18.5 (CED) 23 5.62 19 82.61 1.678 2 0.432 20 86.96 1.971 2 0.373 18 78.26 11.944 2 0.003
    18.5–25 (normal) 193 47.19 135 69.95 165 85.49 99 51.30
    Above 25 (obese) 193 47.19 135 69.95 174 90.16 127 65.80
Education
    Illiterate 3 0.73 2 0.69 2.098 3 0.552 3 0.84 5.514 3 0.138 3 1.23 3.784 3 0.286
    Primary 3 0.73 1 0.35 2 0.56 1 0.41
    Secondary 104 25.43 73 25.26 97 27.02 66 27.05
    Graduate and above 299 73.11 213 73.70 257 71.58 174 71.31
Profession
    Student 200 48.89 143 49.48 1.273 3 0.736 175 48.75 3.322 3 0.345 120 49.18 1.981 3 0.576
    Service 68 16.63 50 17.30 56 15.59 37 15.16
    Business/Self-employed 18 4.41 11 3.81 17 4.74 13 5.33
    Unemployed 123 30.07 85 29.41 111 30.92 74 30.33
Economic impression
    High 59 14.43 40 13.84 0.765 2 0.682 47 13.09 6.098 2 0.047 38 15.57 1.741 2 0.419
    Middle 103 25.18 76 26.30 88 24.51 65 26.64
    Low 247 60.39 173 59.86 224 62.40 141 57.79
Residence area
    Rural 86 21.03 59 20.42 0.222 1 0.638 73 20.33 0.848 1 0.357 52 21.31 0.029 1 0.864
    Urban 323 78.97 230 79.58 286 79.67 192 78.69
Living status
    With family 371 90.71 263 91 0.101 1 0.750 329 91.64 3.042 1 0.081 218 89.34 1.337 1 0.248
    Without family 38 9.29 26 9 30 8.36 26 10.66
Smoking habit
    Non-smoker 392 95.84 277 95.85 0.000 1 0.995 343 95.54 0.665 1 0.415 232 95.08 0.881 1 0.348
    Smoker 17 4.16 12 4.15 16 4.46 12 4.92
Family history of PCOS
    Yes 74 18.09 47 16.26 2.226 1 0.136 68 18.94 1.427 1 0.232 50 20.49 2.349 1 0.125
    No 335 81.91 242 83.74 291 81.06 194 79.51

p-values are significant at 95% confidence interval (p < 0.05). Significant p-values are shown in bold. BMI, body mass index; CED, chronic energy deficiency; N, number.

Lifestyle-related factors of respondents

We presented the lifestyle-related factors of respondents in Table 2. Among respondents, only 22.74% of respondents engaged in regular physical activity, with the majority of them exercising for less than 30 minutes (78%) on fewer than three days per week (78.97%). Among our participants, 24.45% of participants frequently had junk food, and most of them had mixed diet patterns (90.95%). On the questions of "having morning or evening snacks," "skipping any normal meals," and "eating meals on schedule," 7.83%, 40.5%, and 54.03% of respondents, respectively, provided a negative response. A minor proportion of participants consumed more than 8 glasses of water per day (21.03%), followed a birth control method (23.72%), and took oral contraceptive pills (12.96%).

Table 2. Distribution of lifestyle-related factors and their association with mental health problems among the patients suffering from polycystic ovarian syndrome.

Lifestyle-related factors Total (N = 409) Loneliness (N = 289) Generalized anxiety disorder (N = 359) Depressive disorder (N = 244)
n % n % χ2 df p-value n % χ2 df p-value n % χ2 d f p-value
Perform regular physical exercise
    Yes 93 22.74 68 23.53 0.351 1 0.554 85 23.68 1.472 1 0.225 58 23.77 0.367 1 0.545
    No 316 77.26 221 76.47 274 76.32 186 76.23
Physical exercise per day
    Less than 30 minutes 319 78.00 226 78.20 0.024 1 0.876 279 77.72 0.133 1 0.715 201 82.38 6.76 1 0.009
    30 minutes or more 90 22.00 63 21.80 80 22.28 43 17.62
Physical exercise per week
    Less than 3 days 323 78.97 229 79.24 0.042 1 0.838 279 77.72 2.795 1 0.095 193 79.1 0.006 1 0.940
    3 or more days 86 21.03 60 20.76 80 22.28 51 20.90
Frequency of taking junk food
    Occasionally 121 29.59 83 28.72 5.218 3 0.157 104 28.97 1.537 3 0.674 73 29.92 12.9 3 0.005
    Once in a month 45 11 26 8.99 41 11.42 32 13.11
    Once in a week 143 34.96 106 36.68 128 35.65 70 28.69
    Frequently 100 24.45 74 25.61 86 23.96 69 28.28
Diet pattern
    Vegetarian 5 1.22 2 0.69 2.558 2 0.278 5 1.4 2.021 2 0.364 1 0.41 4.37 2 0.112
    Non-vegetarian 32 7.83 24 8.31 26 7.24 22 9.02
    Mixed 372 90.95 263 91 328 91.36 221 90.57
Morning or afternoon snacks
    Always 143 34.96 98 33.91 0.660 2 0.719 128 35.65 0.632 2 0.729 66 27.05 17.6 2 <0.001
    Sometimes 234 57.21 167 57.79 203 56.55 154 63.11
    Never 32 7.83 24 8.30 28 7.8 24 9.84
Skip any regular meals
    Yes 243 59.41 172 59.52 0.004 1 0.948 215 59.89 0.275 1 0.600 161 65.98 10.82 1 0.001
    No 166 40.59 117 40.48 144 40.11 83 34.02
Taking meals on time
    Yes 188 45.97 123 42.56 4.599 1 0.032 160 44.57 2.309 1 0.129 100 40.98 6.04 1 0.014
    No 221 54.03 166 57.44 199 55.43 144 59.02
Daily water consumption
    Less than 8 glasses 154 37.65 113 39.10 5.460 2 0.065 135 37.61 1.062 2 0.588 96 39.34 9.69 2 0.008
    8 glasses 169 41.32 124 42.91 151 42.06 87 35.66
    More than 8 glasses 86 21.03 52 17.99 73 20.33 61 25
Following any birth control method
    Yes 97 23.72 69 23.88 0.014 1 0.907 90 25.07 2.973 1 0.085 47 19.26 6.632 1 0.010
    No 312 76.28 220 76.12 269 74.93 197 80.74
Taking oral contraceptive pills
    Yes 53 12.96 43 14.88 3.221 1 0.073 52 14.48 6.065 1 0.014 30 12.3 0.236 1 0.627
    No 356 87.04 246 85.12 307 85.52 214 87.7

p-values are significant at 95% confidence interval (p < 0.05). Significant p-values are shown in bold. N, number.

Psychometric parameters

Loneliness, generalized anxiety disorder, and depressive disorder were estimated to be 71%, 88%, and 60%, respectively (Fig 1). We estimated the prevalence of loneliness, generalized anxiety disorder, and depressive disorder in association with socio-demographic variables (Table 1). The high prevalence of loneliness was observed in (i) married versus unmarried (50.87% vs 49.13%, p = 0.221), (ii) individuals with BMI below 18.5 versus normal (82.61% vs 69.95%, p = 0.432), (iii) individuals with graduation or higher versus primary education background (73.70% vs 0.35%, p = 0.552), (iv) low versus high economic background (59.86% versus 13.84%, p = 0.682), (v) residing in urban versus rural area (79.58% vs 20.42%, p = 0.638), (vi) staying with versus without family (91% versus 9%, p = 0.750), (vii) non-smoker versus smoker (95.85% vs 4.15%, p = 0.995). The frequency of having generalized anxiety disorder were higher in (i) married versus unmarried (52.37% vs 47.63%, p = 0.630), (ii) individuals with graduation or higher versus primary education background (71.58% vs 0.56%, p = 0.138), (iii) low versus high economic background (62.40% versus 13.09%, p = 0.047), (iv) residing in urban versus rural area (79.67% vs 20.33%, p = 0.357), (v) staying with versus without family (91.64% versus 8.36%, p = 0.081), (vi) non-smoker versus smoker (95.54% vs 4.46%, p = 0.415). Similarly, respondents were more prone to have depressive disorder in (i) married versus unmarried (50.82% vs 49.18%, p = 0.326), (ii) individuals with BMI below 18.5 versus normal (78.26% vs 51.30%, p = 0.003), (iii) individuals with graduation or higher versus primary education background (71.31% vs 0.41%, p = 0.286), (iv) low versus high economic background (57.79% versus 15.57%, p = 0.419), (v) residing in urban versus rural area (78.69% vs 21.31%, p = 0.864), (vi) staying with versus without family (89.34% versus 10.66%, p = 0.248), (vii) non-smoker versus smoker (95.08% vs 4.92%, p = 0.348).

Fig 1. Prevalence and distribution of mental health problems among patients with polycystic ovarian syndrome in Bangladesh.

Fig 1

At the same time, we estimated the prevalence of loneliness, generalized anxiety disorder, and depressive disorder associated with lifestyle-related factors (Table 2). The high prevalence of loneliness was observed in individuals (i) doing physical exercise irregularly versus regularly (76.47% vs 23.53%, p = 0.554), (ii) taking junk food once a week versus once in a month (36.68% vs 8.99%, p = 0.157), (iii) skipping regular meals versus not skipping regular meals (59.52% vs 40.48%, p = 0.948), (iv) taking meal not timely versus timely (57.44% vs 42.56%, p = 0.032), (v) consuming 8 glasses versus more than 8 glasses of water per day (42.91% vs 17.99%, p = 0.065), (iv) not taking versus taking oral contraceptive pills (85.12% vs 14.88%, p = 0.073). The frequency of having generalized anxiety disorder were higher in (i) doing physical exercise irregularly versus regularly (76.32% vs 23.68%, p = 0.225), (ii) doing exercise for less than 3 days versus at least 3 days (77.72% vs 22.28%, p = 0.095), (iii) skipping regular meals versus not skipping regular meals (59.89% vs 40.11%, p = 0.600), (iv) taking meal not timely versus timely (55.43% vs 44.57%, p = 0.129), (v) not following verses following any birth control method (74.93% vs 25.07%, p = 0.085), (vi) not taking versus taking oral contraceptive pills (85.52% vs 14.48%, p = 0.014). Similarly, respondents were more prone to have depressive disorder in individuals (i) doing physical exercise regularly for less than 30 minutes versus at least 30 minutes (82.38% versus 17.62%, p = 0.009), (ii) taking junk food occasionally versus once in a week (29.92% vs 28.69%, p = 0.005), (iii) skipping regular meals versus not skipping regular meals (65.98% vs 34.02%, p = 0.001), (iv) taking meal not timely versus timely (59.02% vs 40.98%, p = 0.014), (v) consuming less than 8 glasses versus more than 8 glasses of water per day (39.34% vs 25%, p = 0.008), (vi) not following verses following any birth control method (80.74% vs 19.26%, p = 0.010).

Regression analysis

We estimated the correlations between the independent and dependent variables of the socio-demographic profile with the help of binary regression analysis (Table 3). The chances of getting depressive disorder among PCOS patients were 0.293 times lower with individuals having BMI below 18.5 and 0.535 times lower with individuals having normal BMI than obese people (p = 0.003). Respondents living with family members were 2.97 times more likely to have a generalized anxiety disorder than respondents living away from family members (OR = 2.97, 95% CI 1.08–8.16, p = 0.034). The probability of having anxiety was 3.22 times higher in the high economic background participants than in the low financial background participants (OR = 3.22, 95% CI 1.28–8.13, p = 0.039). Similarly, we estimated the correlations between the independent and dependent variables of lifestyle-related factors with the help of binary regression analysis (Table 4).

Table 3. Regression analysis of socio-demographic variables and their association with mental health problems among the patients suffering from polycystic ovarian syndrome.

Socio-demographic parameters Loneliness (N = 289) Generalized anxiety disorder (N = 359) Depressive disorder (N = 244)
OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value
Age in years
    15–25 0.828 0.176–3.888 0.963 0.387 0.031–4.816 0.517 1.843 0.406–8.369 0.669
    26–35 0.890 0.207–3.822 0.294 0.029–3.028 1.921 0.460–8.024
    36–45 1 1 1
Marital status
    Married 1.511 0.777–2.939 0.224 1.956 0.753–5.082 0.168 1.329 0.701–2.519 0.384
     1 1 1
BMI (kg/m2)
    Below 18.5 (CED) 0.490 0.160–1.504 0.446 0.884 0.246–3.173 0.377 0.293 0.104–0.820 0.003
    18.5–25 (normal) 0.490 1.374 0.373–5.054 0.535 0.190–1.504
    Above 25 (obese) 1 1 1
Education
    Illiterate 1.230 0.707–2.139 0.681 0.732 0.289–1.856 0.270 0.764 0.444–1.318 0.794
    Primary 0.777 0.053–11.290 0.815 0.537–1.365 0.126 0.105–0.373
    Secondary 0.289 0.016–5.201 0.022 0.000–1.018 1.286 0.074–22.376
    Graduate and above 1 1 1
Profession
    Student 0.577 0.181–1.842 0.584 2.307 0.212–25.116 0.334 1.053 0.307–3.619 0.194
    Service 1.221 0.569–2.620 0.714 0.246–2.074 0.470 0.226–0.979
    Business/Self-employed 0.801 0.389–1.651 0.411 0.133–1.272 0.708 0.345–1.452
    Unemployed 1 1 1
Economic impression
    High 1.162 0.585–2.306 0.841 3.227 1.281–8.131 0.039 0.767 0.382–1.542 0.362
    Middle 1.257 0.587–2.692 1.840 0.702–4.824 1.114 0.516–2.409
    Low 1 1 1
Residence area
    Rural 0.939 0.533–1.653 0.827 0.536 0.246–1.165 0.115 1.182 0.673–2.075 0.561
    Urban 1 1 1
Living status
    With family 1.391 0.626–3.093 0.418 2.976 1.085–8.164 0.034 0.789 0.342–1.822 0.579
    Without family 1 1 1
Smoking habit
    Non-smoker 0.746 0.224–2.488 0.633 0.312 0.029–3.309 0.334 0.766 0.221–2.660 0.675
    Smoker 1 1 1
Family history of PCOS
    Yes 1.553 0.873–2.762 0.134 0.510 0.194–1.340 0.172 0.866 0.479–1.566 0.635
    No 1 1 1

p-values are significant at 95% confidence interval (p < 0.05). Significant p-values are shown in bold. BMI, body mass index; CED, chronic energy deficiency; N, number.

Table 4. Regression analysis of lifestyle-related factors and their association with mental health problems among the patients suffering from the polycystic ovarian syndrome.

Lifestyle-related factors Loneliness (N = 289) Generalized anxiety disorder (N = 359) Depressive disorder (N = 244)
OR df 95% CI p-value OR df 95% CI p-value OR df 95% CI p-value
Perform regular physical
    Yes 0.535 1 0.223–1.286 0.162 0.717 1 0.193–2.662 0.619 0.552 1 0.237–1.286 0.169
    No 1 1 1
Physical exercise per day
    Less than 30 minutes 1.029 1 0.574–1.843 0.925 1.062 1 0.440–2.562 0.893 0.60 1 0.345–1.048 0.073
    30 minutes or more 1 1 1
Physical exercise per week
    Less than 3 days 0.697 1 0293–1.655 0.413 2.264 1 0.549–9.343 0.259 0.660 1 0.282–1.545 0.338
    3 or more days 1 1 1
Frequency of taking junk food
    Occasionally 1.168 2 0.641–2.127 0.615 0.653 2 0.278–1.530 0.591 1.95 2 1.082–3.527 0.078
    Once in a month 0.846 0.494–1.448 0.760 0.344–1.678 1.100 0.651–1.859
    Once in a week 1 1 1
    Frequently 1 1 1
Diet pattern
    Vegetarian 2.985 2 0.388–22.945 0.537 0.000 2 0.000 0.449 11.4 2 0.946–137.669 0.158
    Non-vegetarian 3.580 0.377–33.965 0.000 0.000 10.86 0.766–154.234
    Mixed 1 1 1
Morning or afternoon snacks
    Always 0.759 2 0.452–1.276 0.446 1.304 2 0.604–2.814 0.733 0.52 2 0.320–0.858 0.007
    Sometimes 1.302 0.507–3.339 1.376 0.374–5.056 2.004 0.754–5.326
    Never 1 1 1
Skip any regular meals
    Yes 1.022 1 0.624–1.674 0.932 0.682 1 0.331–1.404 0.299 0.642 1 0.402–1.025 0.064
    No 1 1 1
Taking meals on time
    Yes 1.631 1 1.012–2.626 0.044 1.890 1 0.943–3.787 0.073 1.18 1 0.746–1.881 0.473
    No 1 1 1
Daily water consumption
    Less than 8 glasses 1.861 2 1.016–3.409 0.054 1.758 2 0.740–4.174 0.334 0.41 2 0.222–0.786 0.026
    8 glasses 2.078 1.110–3.890 1.855 0.763–4.507 0.54 0.285–1.053
    More than 8 glasses 1 1 1
Following any birth control
    Yes 1.087 1 0.560–2.111 0.805 0.652 1 0.234–1.816 0.413 1.737 1 0.903–3.343 0.098
    No 1 1 1
Taking oral contraceptive pills
    Yes 0.405 1 0.169–0.970 0.043 0.117 1 0.013–1.056 0.056 0.662 1 0.299–1.466 0.310
    No 1 1 1

p-values are significant at 95% confidence interval (p < 0.05). Significant p-values are shown in bold. N, number.

Discussion

The most frequent ovarian condition related to high androgen levels in women is PCOS [44]. Chronic anovulation, hyperandrogenism, and metabolic abnormalities are all prevalent symptoms in women with PCOS. Women with PCOS are more likely to be obese, have IR, and hence are predisposed to glucose intolerance [45]. According to some recent studies, hyperandrogenemia (HA) and IR have been demonstrated as the core etiology and prime endocrine features of PCOS. The major causes of PCOS are HA and IR, and they can interact with one another in the onset and progression of the disease [46]. Women with PCOS have experienced multiple physical abnormalities, including obesity, acne, and hirsutism, along with prevalent menstrual disorders. This condition includes several psychosocial aspects in addition to numerous physical difficulties [47]. Various psychiatric disorders include depression, generalized anxiety disorder, personality disorders, social phobia, obsessive-compulsive disorder (OCD), attention deficit hyperactivity disorder (ADHD), bipolar affective disorder, schizophrenia, and eating disorders. Depression and generalized anxiety disorder are the highest prevalence of psychiatric disorders among patients with PCOS [48]. The present study was conducted to investigate the mental health problems such as loneliness, generalized anxiety disorder, and depressive disorder among women suffering from PCOS. According to our analysis, from the perspective of the socio-demographic profile, we concluded that marital status, education, financial background, area of residence, smoking habit, and family history of PCOS might be responsible for developing mental health issues among our participants. Therefore, an earlier study suggested that lifestyle change can be an option for the effective management of PCOS [49]. Another study revealed environmental and lifestyle factors contributing poor mental health of patients with PCOS [50]. An absolute correlation could have been established between educational qualifications and loneliness, anxiety, and depression. The respondents who had done graduation or held a degree above graduation complained of experiencing more loneliness, anxiety, and depression than the other participants having educational qualifications other than graduation or above. Financial conditions may have a direct effect on mental health issues. Participants with low economic impressions were going through more mental health problems. Most of our respondents lived with their families, and almost all of them complained of experiencing such mental health problems. From the perspective of lifestyle-related factors, we concluded that physical exercise, duration of physical exercise, food habits, daily water consumption, birth control method, and the use of contraceptive pills might be responsible for developing mental health issues among our respondents. The women who performed physical exercise at least 30 minutes a day for at least 3 days a week had experienced better mental health than other participants. We found that a good food habit, not taking any morning and evening snacks, more than 8 glasses of water consumption per day, all of these lifestyles may contribute to achieving great mental health among PCOS women. We also found that women who were not taking contraceptive pills and not following any birth control methods had some mental health issues.

Few studies have been carried out to assess the mental health problems of women having PCOS. In a study of psychiatric disorders in women with PCOS, women with this condition were shown to have more significant risks for depression and anxiety disorders than the general population [51]. Patients with PCOS have higher mental stress due to clinical manifestations of the menstrual problem, and as a result, patients with PCOS require more extra therapies for their symptoms than others. This extra mental pressure could lead to depressive, and anxiety disorders [52]. It has been suggested by various studies that PCOS has an impaired sexual function that may be responsible for the poorer mental health of these women with a higher prevalence of anxiety and depression [53, 54]. According to one study, generalized anxiety disorder and depressive disorder symptoms in women with PCOS are more closely associated with obesity [55]. Another study found that PCOS women with BMI greater than 30 have higher depression levels than women with lower BMI [53]. Despite this, our research found not much influence of higher BMI or obesity on depressive symptoms or signs of generalized anxiety disorder in women with PCOS.

To the best of our knowledge, our study is the first approach in Bangladesh to assess the mental health problem of PCOS women from the perspective of socio-demographic profile and lifestyle-related factors simultaneously. We found some key factors of the socio-demographic profile, including education, economic impression, marital status, and family history of PCOS, as well as key factors of lifestyle-related factors including the total duration of physical exercise, food habits, daily water consumption that may contribute to the development of loneliness, generalized anxiety disorder, and depressive disorder. As the etiology of the PCOS is not fully known, the socio-demographic profile of respondents may not be a changeable factor, and leading to healthy lifestyle aid in mental health [56], the adaptation of a good lifestyle may help the PCOS women to maintain a life with better mental health. As per our analysis, 71%, 88%, and 60% of respondents are struggling with loneliness, anxiety, and depression, respectively, and the socio-demographic profile and lifestyle-related factors don’t have a direct relationship with such a mental disorder. One earlier meta-analysis reported that the prevalence of depression and anxiety were 36.6% and 41.9% among women suffering from PCOS [57]. It can be concluded that PCOS and its consequences are responsible for increased mental health problems of women suffering from this hormonal disease [58, 59]. The PCOS cases are increasing in Bangladesh over the last decades due to the changed lifestyle and some other demographic factors. However, we do not have actual data regarding the mental health problems due to PCOS. This study’s findings would help the healthcare authorities and allied healthcare professionals in designing the interventional approach to support the women suffering from PCOS. Also, the findings might help to create awareness among the general population about the consequences of PCOS and its preventive measures.

Potential limitations of the study

The shortcomings of this study should be discussed. The use of Google forms for self-reporting surveys may introduce bias. Furthermore, this survey does not include those who do not have an internet connection. The inclusion of offline participants or offline surveys or interviews might have provided a different estimate of our hypothesis. Furthermore, we are unable to examine these mental health concerns over time in our cross-sectional investigation. PCOS was clinically diagnosed by physicians initially a few times back and was not assessed again during or before our data collection. On the other hand, PCOS is thought to be a permanent disorder. Furthermore, due to the cross-sectional nature of this investigation, we were unable to determine causation.

Practical implications

The current study findings have widespread implications. The association of loneliness, generalized anxiety disorder and depressive disorder with PCOS women in Bangladesh is proven. One can easily differentiate the key socio-demographic and lifestyle-related factors that may have contributed to the development of such mental health issues. The healthcare authority should pay attention to the development of guidelines that may converge the physical and psychological health of women with PCOS while physicians give proper care to them. At the same time, this study can contribute to thinking about the mental health of women struggling with PCOS worldwide.

Conclusion

The present study results suggest that a high proportion of women suffering from PCOS have several mental health problems. This additional mental health burden among PCOS patients is due to demographics, physical health, lifestyle factors, psychological issues, and social reasons. Therefore, women suffering from PCOS have high a tendency to develop mental health problems. Based on the present findings, we recommend proper therapeutic interventions, public awareness, and a healthy lifestyle to promote the good mental health of women suffering from PCOS. However, further studies investigating the degree of loneliness, anxiety, and depression among women with PCOS to know the actual gravity of the issue.

Acknowledgments

We thank all the participants for their cooperation to this study.

Data Availability

All relevant data are within the paper.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Ajmal N, Khan SZ, Shaikh R. Polycystic ovary syndrome (PCOS) and genetic predisposition: A review article. Eur J Obstet Gynecol Reprod Biol X. 2019; 3:100060. doi: 10.1016/j.eurox.2019.100060 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018; 182:27–36. doi: 10.1016/j.jsbmb.2018.04.008 [DOI] [PubMed] [Google Scholar]
  • 3.Meier RK. Polycystic Ovary Syndrome. Nurs Clin North Am. 2018;53(3):407–420. doi: 10.1016/j.cnur.2018.04.008 [DOI] [PubMed] [Google Scholar]
  • 4.Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013; 6:1–13. doi: 10.2147/CLEP.S37559 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wojciechowska A, Osowski A, Jóźwik M, Górecki R, Rynkiewicz A, Wojtkiewicz J. Inositols’ Importance in the Improvement of the Endocrine-Metabolic Profile in PCOS. Int J Mol Sci. 2019; 20(22):5787. doi: 10.3390/ijms20225787 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Madnani N, Khan K, Chauhan P, Parmar G. Polycystic ovarian syndrome. Indian J Dermatol Venereol Leprol. 2013; 79(3):310–321. doi: 10.4103/0378-6323.110759 [DOI] [PubMed] [Google Scholar]
  • 7.Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010; 8:41. doi: 10.1186/1741-7015-8-41 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Tasali E, Van Cauter E, Ehrmann DA. Polycystic Ovary Syndrome and Obstructive Sleep Apnea. Sleep Med Clin. 2008; 3(1):37–46. doi: 10.1016/j.jsmc.2007.11.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Barthelmess EK, Naz RK. Polycystic ovary syndrome: current status and future perspective. Front Biosci (Elite Ed). 2014; 6:104–119. doi: 10.2741/e695 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Svendsen PF, Nilas L, Nørgaard K, Jensen JE, Madsbad S. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Hum Reprod. 2008; 23(9):2113–2121. doi: 10.1093/humrep/den211 [DOI] [PubMed] [Google Scholar]
  • 11.Corbould A, Kim YB, Youngren JF, et al. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab. 2005; 288(5):E1047–E1054. doi: 10.1152/ajpendo.00361.2004 [DOI] [PubMed] [Google Scholar]
  • 12.Dunaif A, Finegood DT. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1996;81(3):942–947. doi: 10.1210/jcem.81.3.8772555 [DOI] [PubMed] [Google Scholar]
  • 13.Deswal R, Narwal V, Dang A, Pundir CS. The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. J Hum Reprod Sci. 2020; 13(4):261–271. doi: 10.4103/jhrs.JHRS_95_18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG. 2006; 113(10):1210–1217. doi: 10.1111/j.1471-0528.2006.01008.x [DOI] [PubMed] [Google Scholar]
  • 15.Islam S, Pathan F, Ahmed T. Clinical and Biochemical Characteristics of Polycystic Ovarian Syndrome among Women in Bangladesh. Mymensingh Med J. 2015; 24(2):310–318. [PubMed] [Google Scholar]
  • 16.Behboodi Moghadam Z, Fereidooni B, Saffari M, Montazeri A. Measures of health-related quality of life in PCOS women: a systematic review. Int J Womens Health. 2018; 10:397–408. doi: 10.2147/IJWH.S165794 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Nasiri Amiri F, Ramezani Tehrani F, Simbar M, Montazeri A, Mohammadpour Thamtan RA. The experience of women affected by polycystic ovary syndrome: a qualitative study from Iran. Int J Endocrinol Metab. 2014; 12(2):e13612. doi: 10.5812/ijem.13612 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Authier M, Normand C, Jego M, Gaborit B, Boubli L, Courbiere B. Qualitative study of self- reported experiences of infertile women with polycystic ovary syndrome through on-line discussion forums. Ann Endocrinol (Paris). 2020; 81(5):487–492. doi: 10.1016/j.ando.2020.07.1110 [DOI] [PubMed] [Google Scholar]
  • 19.Elsenbruch S, Hahn S, Kowalsky D, et al. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003; 88(12):5801–5807. doi: 10.1210/jc.2003-030562 [DOI] [PubMed] [Google Scholar]
  • 20.Asdaq SMB, Jomah S, Hasan R, et al. Impact of polycystic ovary syndrome on eating behavior, depression and health related quality of life: A cross-sectional study in Riyadh. Saudi J Biol Sci. 2020; 27(12):3342–3347. doi: 10.1016/j.sjbs.2020.08.039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Barry JA, Qu F, Hardiman PJ. An exploration of the hypothesis that testosterone is implicated in the psychological functioning of women with polycystic ovary syndrome (PCOS). Med Hypotheses. 2018; 110:42–45. doi: 10.1016/j.mehy.2017.10.019 [DOI] [PubMed] [Google Scholar]
  • 22.Podfigurna-Stopa A, Luisi S, Regini C, et al. Mood disorders and quality of life in polycystic ovary syndrome. Gynecol Endocrinol. 2015; 31(6):431–434. doi: 10.3109/09513590.2015.1009437 [DOI] [PubMed] [Google Scholar]
  • 23.Hoeger KM, Dokras A, Piltonen T. Update on PCOS: Consequences, Challenges, and Guiding Treatment. J Clin Endocrinol Metab. 2021; 106(3):e1071–e1083. doi: 10.1210/clinem/dgaa839 [DOI] [PubMed] [Google Scholar]
  • 24.Yildiz BO, Knochenhauer ES, Azziz R. Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab. 2008; 93(1):162–168. doi: 10.1210/jc.2007-1834 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril. 2007; 87(6):1369–1376. doi: 10.1016/j.fertnstert.2006.11.039 [DOI] [PubMed] [Google Scholar]
  • 26.Chaudhari AP, Mazumdar K, Mehta PD. Anxiety, Depression, and Quality of Life in Women with Polycystic Ovarian Syndrome. Indian J Psychol Med. 2018; 40(3):239–246. doi: 10.4103/IJPSYM.IJPSYM_561_17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Yin X, Ji Y, Chan CLW, Chan CHY. The mental health of women with polycystic ovary syndrome: a systematic review and meta-analysis. Arch Womens Ment Health. 2021; 24(1):11–27. doi: 10.1007/s00737-020-01043-x [DOI] [PubMed] [Google Scholar]
  • 28.Dokras A. Mood and anxiety disorders in women with PCOS. Steroids. 2012;77(4):338–341. doi: 10.1016/j.steroids.2011.12.008 [DOI] [PubMed] [Google Scholar]
  • 29.Livadas S, Chaskou S, Kandaraki AA, et al. Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome. Clin Endocrinol (Oxf). 2011; 75(5):698–703. doi: 10.1111/j.1365-2265.2011.04122.x [DOI] [PubMed] [Google Scholar]
  • 30.Islam MR, Hossain MJ. Social Stigma and Suicide in Bangladesh: The Covid-19 has Worsened the Situation. Chronic Stress (Thousand Oaks). 2021; 5:24705470211035602. doi: 10.1177/24705470211035602 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Rahman FI, Ether SA, Islam MR. The growing rape incidences seems an epidemic turn of sexual violence in Bangladesh: A letter to the editor. Women’s Health (Lond). 2021; 17:17455065211063285. doi: 10.1177/17455065211063285 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Rahman FI, Islam MR. Sexual violence against woman at quarantine center during coronavirus disease 2019 in Bangladesh: Risk factors and recommendations. Women’s Health (Lond). 2021; 17:17455065211043851. doi: 10.1177/17455065211043851 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Hossain MJ, Soma MA, Bari MS, Emran TB, Islam MR. COVID-19 and child marriage in Bangladesh: emergency call to action. BMJ Paediatr Open. 2021; 5(1):e001328. doi: 10.1136/bmjpo-2021-001328 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Islam MR, Hossain MJ. Increments of gender-based violence amid COVID-19 in Bangladesh: A threat to global public health and women’s health. Int J Health Plann Manage. 2021; 36(6):2436–2440. doi: 10.1002/hpm.3284 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross- cultural adaptation of self-report measures. Spine (Phila Pa 1976). 2000;25(24):3186–3191. doi: 10.1097/00007632-200012150-00014 [DOI] [PubMed] [Google Scholar]
  • 36.Ganguly S, Samanta M, Roy P, Chatterjee S, Kaplan DW, Basu B. Patient health questionnaire-9 as an effective tool for screening of depression among Indian adolescents. J Adolesc Health. 2013; 52(5):546–551. doi: 10.1016/j.jadohealth.2012.09.012 [DOI] [PubMed] [Google Scholar]
  • 37.Das R, Hasan MR, Daria S, Islam MR. Impact of COVID-19 pandemic on mental health among general Bangladeshi population: a cross-sectional study. BMJ Open. 2021; 11(4):e045727. doi: 10.1136/bmjopen-2020-045727 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Islam MR, Daria S, Das R, Hasan MR. A nationwide dataset on the mental health of the Bangladeshi population due to the COVID-19 pandemic. Data Brief. 2021; 38:107347. doi: 10.1016/j.dib.2021.107347 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Sun Y, Fu Z, Bo Q, Mao Z, Ma X, Wang C. The reliability and validity of PHQ-9 in patients with major depressive disorder in psychiatric hospital. BMC Psychiatry. 2020; 20(1):474. doi: 10.1186/s12888-020-02885-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Maurer DM. Screening for depression. Am Fam Physician. 2012;85(2):139–144. [PubMed] [Google Scholar]
  • 41.Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9):606–613. doi: 10.1046/j.1525-1497.2001.016009606.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092–1097. doi: 10.1001/archinte.166.10.1092 [DOI] [PubMed] [Google Scholar]
  • 43.Russell DW. UCLA Loneliness Scale (Version 3): reliability, validity, and factor structure. J Pers Assess. 1996; 66(1):20–40. doi: 10.1207/s15327752jpa6601_2 [DOI] [PubMed] [Google Scholar]
  • 44.Bachelot A. Polycystic ovarian syndrome: clinical and biological diagnosis. Ann Biol Clin (Paris). 2016;74(6):661–667. doi: 10.1684/abc.2016.1184 [DOI] [PubMed] [Google Scholar]
  • 45.Trikudanathan S. Polycystic ovarian syndrome. Med Clin North Am. 2015; 99(1):221–235. doi: 10.1016/j.mcna.2014.09.003 [DOI] [PubMed] [Google Scholar]
  • 46.Wang J, Wu D, Guo H, Li M. Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. Life Sci. 2019; 236:116940. doi: 10.1016/j.lfs.2019.116940 [DOI] [PubMed] [Google Scholar]
  • 47.Ekramzadeh M, Hajivandi L, Noroozi M, Mostafavi F. Psychological Experiences of Adolescent Girls with Polycystic Ovary Syndrome: A Qualitative Study. Iran J Nurs Midwifery Res. 2020; 25(4):341–347. doi: 10.4103/ijnmr.IJNMR_276_19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Rodriguez-Paris D, Remlinger-Molenda A, Kurzawa R, et al. Psychiatric disorders in women with polycystic ovary syndrome. Psychiatr Pol. 2019; 53(4):955–966. doi: 10.12740/PP/OnlineFirst/93105 [DOI] [PubMed] [Google Scholar]
  • 49.Ee C, Pirotta S, Mousa A, Moran L, Lim S. Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success. BMC Endocr Disord. 2021;21(1):234. doi: 10.1186/s12902-021-00890-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Zhang B, Zhou W, Shi Y, Zhang J, Cui L, Chen ZJ. Lifestyle and environmental contributions to ovulatory dysfunction in women of polycystic ovary syndrome. BMC Endocr Disord. 2020;20(1):19. doi: 10.1186/s12902-020-0497-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Brutocao C, Zaiem F, Alsawas M, Morrow AS, Murad MH, Javed A. Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine. 2018; 62(2):318–325. doi: 10.1007/s12020-018-1692-3 [DOI] [PubMed] [Google Scholar]
  • 52.Ahmadi M, Faramarzi M, Basirat Z, Kheirkhah F, Chehrazi M, Ashabi F. Mental and personality disorders in infertile women with polycystic ovary: a case-control study. Afr Health Sci. 2020; 20(3):1241–1249. doi: 10.4314/ahs.v20i3.28 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Karsten MDA, Wekker V, Groen H, et al. The role of PCOS in mental health and sexual function in women with obesity and a history of infertility. Hum Reprod Open. 2021; 2021(4):hoab038. doi: 10.1093/hropen/hoab038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Pastoor H, Timman R, de Klerk C, M Bramer W, Laan ET, Laven JS. Sexual function in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biomed Online. 2018; 37(6):750–760. doi: 10.1016/j.rbmo.2018.09.010 [DOI] [PubMed] [Google Scholar]
  • 55.Veltman-Verhulst SM, Boivin J, Eijkemans MJ, Fauser BJ. Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update. 2012; 18(6):638–651. doi: 10.1093/humupd/dms029 [DOI] [PubMed] [Google Scholar]
  • 56.Walsh R. Lifestyle and mental health. Am Psychol. 2011;66(7):579–592. doi: 10.1037/a0021769 [DOI] [PubMed] [Google Scholar]
  • 57.Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017;32(5):1075–1091. doi: 10.1093/humrep/dex044 [DOI] [PubMed] [Google Scholar]
  • 58.Doretto L, Mari FC, Chaves AC. Polycystic Ovary Syndrome and Psychotic Disorder. Front Psychiatry. 2020; 11:543. doi: 10.3389/fpsyt.2020.00543 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Farkas J, Rigó A, Demetrovics Z. Psychological aspects of the polycystic ovary syndrome. Gynecol Endocrinol. 2014; 30(2):95–99. doi: 10.3109/09513590.2013.852530 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Kenji Hashimoto

19 Apr 2022

PONE-D-21-40627Prevalence and associated risk factors for mental health problems among patients with polycystic ovary syndrome in Bangladesh: A nationwide cross- sectional studyPLOS ONE

Dear Dr. Islam,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Two reviewers addressed several major concerns about your manuscript. Please revise your manuscript according to reviewer's comments.

Please submit your revised manuscript by Jun 03 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Kenji Hashimoto, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I reviewed the manuscript entitled 'Prevalence and associated risk factors for mental health problems among patients withpolycystic ovary syndrome in Bangladesh: A nationwide cross-sectional study' and definitely this has merits in terms of women's health care.However, the following points have to be considered very seriously regarding the manuscript.1. In the abstract, focus on the method and result in more details. Do not put more words in the introduction. Secondly, the conclusion should be concise and must be a very accurate reflection of the study 2. The introduction section is written like a literature review. Reduce a minimum of 35 % of the unnecessary content. This would also help you in reducing a number of references.3. The aim of the study is very superficially presented. It should be very clear and concise.4. In the study design, what is the meaning od expected to have. It means you have not considered it yet.5. The mentioned sentence 'Furthermore,when we gathered the data, all respondents were of Bangladeshi nationality and lived inBangladesh' is one of the example of poor language editing. Revise whole manuscript for English grammar and language.6. What about the validation of the questionnaire.7. The details mentioned in DATA COLLECTION SUBHEADING are really annoying to the readers.8. Remove the unnecessary sentences or repeating sentences form the method section. make it more presented scientifically.9. For one method or instrument used, put one valid reference only. I do not understand why there is too many references are used in Generalized Anxiety Disorder Scale and Loneliness Scale.10. We also utilized bar graphs to compare the distribution of mental health problemsaccording to the severity.---Not needed here to write.11. , HA (hyperandrogenemia) and IR (insulin resistance)- First write full form then abbreviations.12. Remove this-----However, this study contains several noteworthy findings. To begin, the current study assessedthe three primary psychological difficulties associated with women having PCOS. As we usedGoogle forms for data collection, which allowed for the collecting of data from people of allsocioeconomic backgrounds and educational levels in a timely manner. Moreover, we employedthe mental health assessment scales in Bangla, which ensured that the questions were clearlyunderstood.---from the manuscript.13. Conclusion looks lengthy. I recommend making it concise.14. All the references must mention the DOI.

Reviewer #2: This is a valuable study about the mental health problem of PCOS women from the perspective of socio-demographic profile and lifestyle-related factors in Bangladesh.

However, there are some comments to the author.

1. What is the novelty of this study? Is it only that it is the first study in Bangladesh? The author should clearly state the novelty.

2. What is the message in Figure 1? The author should provide a discussion comparing the results with previous reports.

3. In Results, the description “Regression analysisのRespondents who took morning or afternoon snacks sometimes were more likely to have the depressive disorder than the respondents who never took snacks (OR=2.00, 95% CI 0.75-5.32, p=0.007)” is inappropriate because the 95% CI straddles 1.

4. In Discussion, there is the description “According to our analysis, from the perspective of the socio-demographic profile, we concluded that marital status, education, financial background, area of residence, smoking habit, and family history of PCOS might be responsible for developing mental health issues among our participants.” More consideration should be given to each of these factors. How does this compare to previous reports? The background of significant differences in each factor should be examined in detail.

5. In Discussion, repeated mention of the result is not required. “About 59.86%, 62.40%, and 57.79% of participants with low economic backgrounds were suffering from loneliness, anxiety, and depressive disorder. Almost half of the women among our participants have complained about their married life which was responsible for their poor mental health. According to our findings, women living in urban area (loneliness=79.58%, generalized anxiety disorder=78.67%, depressive disorder=78.69%), having no smoking habit (loneliness=95.85%, generalized anxiety disorder=95.54%, depressive disorder=95.08%), and having no family history of PCOS (loneliness=53.74%, generalized anxiety disorder=81.06%, depressive disorder=79.51%) might be more at risk of mental health problems.”

6. In Discussion, what is the meaning of a, b and c in the description “As per our analysis, the a%, b%, and c% of respondents are struggling with loneliness, anxiety, and depression, respectively”?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr. Mumammad Sayeed Akhtar

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: review1.docx

PLoS One. 2022 Jun 22;17(6):e0270102. doi: 10.1371/journal.pone.0270102.r002

Author response to Decision Letter 0


23 May 2022

Dear Editors and Reviewers,

Thank you for your letter and the reviewers' comments on our manuscript entitled "Prevalence and associated risk factors for mental health problems among patients with polycystic ovary syndrome in Bangladesh: A nationwide cross- sectional study" (Manuscript ID PONE-D-21-40627). All the comments were valuable and helpful to the revision and improvement of the manuscript. We have carefully studied the comments and made corrections, which we hope will merit your approval. We marked the revised portions using track changes. Our point-by-point answers to the reviewers’ comments appear at the end of this letter.

We earnestly appreciate the Editors'/Reviewers' work. We hope that after this revision, the paper will be deemed fit for publication. We would be glad to respond to any further questions and comments that you may have.

Once again, thank you very much for your comments and suggestions.

Best regards,

Md. Rabiul Islam, PhD

Assistant Professor, Department of Pharmacy, University of Asia Pacific, 74/A Green Road, Farmgate, Dhaka-1205, Bangladesh. Email: robi.ayaan@gmail.com; Cell: +8801916031831

Point by point authors’ responses to the reviewers

Manuscript ID PONE-D-21-40627

Title: Prevalence and associated risk factors for mental health problems among patients with polycystic ovary syndrome in Bangladesh: A nationwide cross- sectional study

Reviewer #1

I reviewed the manuscript entitled 'Prevalence and associated risk factors for mental health problems among patients with polycystic ovary syndrome in Bangladesh: A nationwide cross-sectional study' and definitely this has merits in terms of women's health care. However, the following points have to be considered very seriously regarding the manuscript.

Author’s response

Thank you for your review and encouraging comments on our manuscript. We have addressed all your observation very carefully in our revised manuscript.

Comment 1. In the abstract, focus on the method and result in more details. Do not put more words in the introduction. Secondly, the conclusion should be concise and must be a very accurate reflection of the study

Author’s response

Thank you for your observation. We have now revised the abstract following your suggestion (Page 2, line 5-34; page 3, line 1-2).

Comment 2. The introduction section is written like a literature review. Reduce a minimum of 35 % of the unnecessary content. This would also help you in reducing a number of references.

Author’s response

Thank you for your suggestion. We have now reduced the unnecessary contents from the introduction part of our manuscript.

Comment 3. The aim of the study is very superficially presented. It should be very clear and concise.

Author’s response

Thank you again for your valuable suggestion. We have now written the aim of this study very clearly and concisely in the revised manuscript (page 5, line 16-20).

Comment 4. In the study design, what is the meaning od expected to have. It means you have not considered it yet.

Author’s response

Thank you for your opinion. We have corrected this accordingly (page 5, line 26; page 6, line 4).

Comment 5. The mentioned sentence 'Furthermore, when we gathered the data, all respondents were of Bangladeshi nationality and lived in Bangladesh' is one of the example of poor language editing. Revise whole manuscript for English grammar and language.

Author’s response

Thank you for your comments and suggestions. According to your advice, the whole manuscript has been edited by a person who is proficient in written English. We hope that after this language edit, the paper will be considered suitable for publication.

Comment 6. What about the validation of the questionnaire.

Author’s response

Thank you for your observation. The questionnaires/scales used in this study are not validated. However, the questionnaires/scales were pilot-tested and we discussed this information at the method section (page 6, line 20-24).

Comment 7. The details mentioned in DATA COLLECTION SUBHEADING are really annoying to the readers.

Author’s response

Thank you for your opinion. We have now deleted Data Collection subheading and merged the relevant text with previous section (page 6, line 25).

Comment 8. Remove the unnecessary sentences or repeating sentences form the method section. make it more presented scientifically.

Author’s response

Thank you for your valuable observation. We edited the whole method section and deleted unnecessary and repeating sentences.

Comment 9. For one method or instrument used, put one valid reference only. I do not understand why there is too many references are used in Generalized Anxiety Disorder Scale and Loneliness Scale.

Author’s response

Thank you for your suggestion. We have now mentioned one valid reference for Generalized Anxiety Disorder Scale and another one for Loneliness Scale (page 7, line 28, ref. 42; page 8, line 6, ref. 43).

Comment 10. We also utilized bar graphs to compare the distribution of mental health problems according to the severity. ---Not needed here to write.

Author’s response

Thank you for your opinion. We have deleted this information from revised version (page 8 line 16-17).

Comment 11. HA (hyperandrogenemia) and IR (insulin resistance)- First write full form then abbreviations.

Author’s response

Thank you for your observation. We have corrected this.

Comment 12. Remove this-----However, this study contains several noteworthy findings. To begin, the current study assessed the three primary psychological difficulties associated with women having PCOS. As we used Google forms for data collection, which allowed for the collecting of data from people of all socioeconomic backgrounds and educational levels in a timely manner. Moreover, we employed the mental health assessment scales in Bangla, which ensured that the questions were clearly understood. ---from the manuscript.

Author’s response

Thank you for your suggestion. We have deleted this portion for the revised manuscript (page 14, line 31-32; page 15, line 1-4.).

Comment 13. Conclusion looks lengthy. I recommend making it concise.

Author’s response

Thank you for your observation. We present a concise conclusion in the revised manuscript.

Comment 14. All the references must mention the DOI

Author responses

Thank you for your suggestion. We added DOI number/link with all references.

Reviewer #2

This is a valuable study about the mental health problem of PCOS women from the perspective of socio-demographic profile and lifestyle-related factors in Bangladesh.

However, there are some comments to the author.

Author’s response

Thank you for your review and appreciation. We have made all necessary revisions following your suggestion.

Comment 1. What is the novelty of this study? Is it only that it is the first study in Bangladesh? The author should clearly state the novelty.

Author’s response

Thank you for your observation. The PCOS cases in increasing in Bangladesh over last decades due to the changed lifestyle and some other demographic factors. However, we do not have actual data regarding the mental health problems due to PCOS. This study findings would help the healthcare authorities and allied healthcare professionals to design the interventional approach to support the women suffering from PCOS. Also, the findings might help to create awareness among the general population about the consequences of PCOS and preventives measures of it (page 14, line 14-19).

Comment 2. What is the message in Figure 1? The author should provide a discussion comparing the results with previous reports.

Author’s response

Thank you for your suggestion. We have now compared our findings with previous reports in the revised manuscript (page 14, line 7-11).

Comment 3. In Results, the description “Regression analysisのRespondents who took morning or afternoon snacks sometimes were more likely to have the depressive disorder than the respondents who never took snacks (OR=2.00, 95% CI 0.75-5.32, p=0.007)” is inappropriate because the 95% CI straddles 1.

Author’s response

Thank you for your observation. We eliminated this portion from result section (page 11, line 19-21).

Comment 4. In Discussion, there is the description “According to our analysis, from the perspective of the socio-demographic profile, we concluded that marital status, education, financial background, area of residence, smoking habit, and family history of PCOS might be responsible for developing mental health issues among our participants.” More consideration should be given to each of these factors. How does this compare to previous reports? The background of significant differences in each factor should be examined in detail.

Author’s response

Thank you for your valuable suggestion. We have now added some information from earlier studies to compare these factors with present findings (page 12, line 19-21).

Comment 5. In Discussion, repeated mention of the result is not required. “About 59.86%, 62.40%, and 57.79% of participants with low economic backgrounds were suffering from loneliness, anxiety, and depressive disorder. Almost half of the women among our participants have complained about their married life which was responsible for their poor mental health. According to our findings, women living in urban area (loneliness=79.58%, generalized anxiety disorder=78.67%, depressive disorder=78.69%), having no smoking habit (loneliness=95.85%, generalized anxiety disorder=95.54%, depressive disorder=95.08%), and having no family history of PCOS (loneliness=53.74%, generalized anxiety disorder=81.06%, depressive disorder=79.51%) might be more at risk of mental health problems.”

Author’s response

Thank you for your valuable suggestion. We omitted this portion from our revised manuscript (page 12, line 27-32; page 13, line 1-3).

Comment 6. In Discussion, what is the meaning of a, b and c in the description “As per our analysis, the a%, b%, and c% of respondents are struggling with loneliness, anxiety, and depression, respectively”?

Author’s response

Thank you for your observation. We have corrected this information in the revised manuscript (page 14, line 7).

Decision Letter 1

Kenji Hashimoto

6 Jun 2022

Prevalence and associated risk factors for mental health problems among patients with polycystic ovary syndrome in Bangladesh: A nationwide cross- sectional study

PONE-D-21-40627R1

Dear Dr. Islam,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Kenji Hashimoto, PhD

Section Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. Look for PLOSONE policies regarding data and publication.

2. Please go thoroughly again regarding any typographical errors.

Thanks

Reviewer #2: The authors have adequately addressed my comments and made all data underlying the findings in their manuscript fully available. I think this study is acceptable for publishing in PLOS ONE.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Attachment

Submitted filename: Final Comments EMID.docx

Acceptance letter

Kenji Hashimoto

13 Jun 2022

PONE-D-21-40627R1

Prevalence and associated risk factors for mental health problems among patients with polycystic ovary syndrome in Bangladesh: A nationwide cross- sectional study

Dear Dr. Islam:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Kenji Hashimoto

Section Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: review1.docx

    Attachment

    Submitted filename: Final Comments EMID.docx

    Data Availability Statement

    All relevant data are within the paper.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES